22413
document
Montelukast treatment of moderate to severe atopic dermatitis in adults : a randomized , double-blind , placebo-controlled trial . In a randomized , double-blind , placebo-controlled 4-week trial , 59 patients with moderate to severe atopic dermatitis were treated orally with 10 mg of the leukotriene antagonist montelukast . Forty-seven patients completed the study . No difference in efficacy was seen among patients who received montelukast and the group given a placebo .
22414
Intervention_Control
Montelukast treatment
22415
Intervention_Control
placebo-controlled
22416
Intervention_Control
placebo-controlled
22417
Intervention_Physical
leukotriene antagonist montelukast
22418
Intervention_Physical
montelukast
22419
Intervention_Control
placebo
22420
Outcome_Other
No difference in efficacy
22421
Participant_Condition
severe atopic dermatitis in adults :